Viking Therapeutics: Potential Winner In Competitive Obesity Drug Race

Sasha Brazhnik/iStock via Getty Images +3.02 (5.93%) 100.00 90.00 80.00 70.00 60.00 40.00 54.03 50.00 30.00 10.00 Jul The weight loss drug sector is seeing an incecasingly intensified drug development focus, causing a small player like Viking Therapeuties, Inc. (NASDAQ:VKTX) to The wegen world, broken in metelings meaning due, est lest, but the fear is not one mail pay than your man partier for O.P-1 man arte norse. slip. The small biotech has has Potentially Crowded Market VIKING Goldman Sachs has jumped M ...